Spring allergy season is underway across the United States, and federal data show pollen seasons—especially ragweed—are starting earlier and lasting longer in many regions. Here’s what the evidence says, who is most at risk, and how to protect yourself and your family.
Federal minimum staffing standards for nursing homes are now phasing in nationwide. Here’s what the rule requires, when changes take effect, and what families should realistically expect in 2026.
Enhanced Affordable Care Act premium tax credits ended December 31, 2025. Here’s how 2026 Marketplace coverage works under the standard subsidy formula, who is most affected, what protections remain, and what families can do now.
Federal agencies extended pandemic-era telehealth flexibilities for prescribing certain controlled substances, including ADHD stimulants, through December 31, 2025. Here’s what that meant, where things stand in March 2026, and how patients can avoid treatment disruptions.
Clear, evidence-based health reporting is more than a writing style—it’s a public health tool. Here’s how federal health literacy guidance and research on medical evidence explain why plain-language communication protects patients and communities.
Federal climate data and peer-reviewed research show that pollen seasons in much of the United States are starting earlier and lasting longer. Here’s what the science says—and how families can reduce symptoms and asthma risk this spring.
Federal regulators have finalized the first nationwide minimum staffing standards for Medicare- and Medicaid-certified nursing homes. Here’s what 24/7 RN coverage and new hourly minimums mean for residents and families in 2026.
The finalized 2026 ACA Marketplace rules shape how premium tax credits are calculated, who qualifies for financial help, and what households should review before enrolling. Here’s what to check now to avoid surprise costs and coverage gaps.
Federal telehealth flexibilities allowed many ADHD stimulant prescriptions to be written without an in-person exam through December 31, 2025. Here’s what changed, where things stand in March 2026, and how patients can avoid treatment disruptions.
CDC and ACIP have updated guidance for COVID-19, flu, and RSV vaccines for the 2025–2026 respiratory season. Here’s who should get vaccinated, whether shots can be given together, and how Medicare, Medicaid, and private insurance coverage works.
Spring allergy season is underway across the United States. Here’s what current CDC, NIH, and EPA guidance says about pollen, asthma risk, climate trends, and practical steps to protect your health.
The CDC’s 2026 adult immunization schedule includes updated guidance on COVID-19, influenza, RSV, pneumococcal, and shingles vaccines. Here’s what adults 65+ and families with loved ones in nursing homes need to know now.
Federal data show continued high enrollment in ACA Marketplace plans heading into 2026. Here’s what current premium tax credit rules, subsidy uncertainty, and new federal guidance could mean for your monthly costs and coverage stability.
Federal telehealth flexibilities for prescribing ADHD stimulants were extended through December 31, 2025, while medication shortages continue into 2026. Here’s what patients and families across the United States should know about access, insurance, and practical next steps.
CDC surveillance updates in early 2026 show ongoing measles activity in multiple states. Here’s what families need to know about symptoms, vaccination, exposure, and protecting vulnerable community members.
Federal mental health funding for 2026 places renewed focus on the 988 Suicide & Crisis Lifeline and Certified Community Behavioral Health Clinics. Here’s what that could mean for crisis response, wait times, and access to care across the United States.
Medicare’s 2026 physician payment rule changes how doctors are paid for office visits, preventive services, telehealth, and chronic care. Here’s what that could mean for appointment access, screenings, and small or rural practices.
Starting in 2026, many Medicare Advantage, Medicaid, CHIP, and Marketplace plans must publicly report how often they approve or deny prior authorization requests and how long decisions take. Here’s what that new transparency could mean for patients and clinicians.
A temporary Medicaid funding deferral in Minnesota has raised questions about coverage, provider payments, and federal oversight. Here’s what enrollees and healthcare providers should understand about how Medicaid financing works and what could happen next.
The FDA has updated its shortage listings and enforcement posture around compounded semaglutide and tirzepatide. Here’s what that could mean for patients who rely on these medications for diabetes or weight management.
Federal regulators say current evidence does not show a clear link between GLP-1 weight-loss drugs and suicidal thoughts. Here’s what the FDA reviewed, what the data show, and what patients should watch for.
The 2025–2030 Dietary Guidelines for Americans place a stronger emphasis on health equity, cultural food patterns, and structural barriers to healthy eating. Here’s what that could mean for school meals, SNAP and WIC, healthcare settings, and everyday families.
End of content
End of content
